Skip to main content

Publications searcher

The science produced by our scientists is very important. In 2022, 1,629 papers were published in scientific journals with a global impact factor of over 15,000 points.

Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial.

PMID: 19688338
Journal: DIABETOLOGIA
Year: 2009
Reference: Diabetologia. 2009 Oct;52(10):2046-55.
Impact factor: 6.418
Publication type: Paper in international publication
Authors: Russell-Jones, D, Vaag, A, Schmitz, O, Sethi, B K, Lalic, N, Antic, S, Zdravkovic, M, Ravn, G M, Simo, R et al.
DOI: 10.1007/s00125-009-1472-y

Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial.

PMID: 19688338
Journal: DIABETOLOGIA
Year: 2009
Reference: Diabetologia. 2009 Oct;52(10):2046-55.
Impact factor:
Publication type: Paper in international publication
Authors: Antic, S; Lalic, N; Ravn, G M; Russell-Jones, D; Schmitz, O; Sethi, B K; Simo, R; Vaag, A; Zdravkovic, M et al.
DOI: 10.1007/s00125-009-1472-y

Livedo racemosa as a marker of increased risk of recurrent thrombosis in patients with negative anti-phospholipid antibodies.

PMID: 19403146
Journal: MEDICINA CLINICA
Year: 2009
Reference: Med Clin (Barc). 2009 May 30;132(20):767-71.
Impact factor: 1.258
Publication type: Paper in national publication
Authors: Martinez-Valle, Ferran, Balada, Eva, Solans-Laque, Roser, Vilardell-Tarres, Miquel, Selva-O'Callaghan, Albert, Ordi-Ros, Josep et al.
DOI: 10.1016/j.medcli.2008.09.044

Livedo racemosa as a marker of increased risk of recurrent thrombosis in patients with negative anti-phospholipid antibodies.

PMID: 19403146
Journal: MEDICINA CLINICA
Year: 2009
Reference: Med Clin (Barc). 2009 May 30;132(20):767-71.
Impact factor:
Publication type: Paper in national publication
Authors: Balada, Eva; Martinez-Valle, Ferran; Ordi-Ros, Josep; Selva-O'Callaghan, Albert; Solans-Laque, Roser; Vilardell-Tarres, Miquel et al.
DOI: 10.1016/j.medcli.2008.09.044

Longitudinal pubertal growth according to age at pubertal growth spurt onset: data from a Spanish study including 458 children (223 boys and 235 girls).

PMID: 19845122
Journal: JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM
Year: 2009
Reference: J Pediatr Endocrinol Metab. 2009 Aug;22(8):715-26.
Impact factor: 0.938
Publication type: Paper in international publication
Authors: Ferrandez, Angel, Carrascosa, Antonio, Audi, Laura, Baguer, Luis, Rueda, Carmen, Bosch-Castane, Juan, Gussinye, Miquel, Yeste, Diego, Labarta, Jose Ignacio, Mayayo, Esteban et al.
DOI:

Longitudinal pubertal growth according to age at pubertal growth spurt onset: data from a Spanish study including 458 children (223 boys and 235 girls).

PMID: 19845122
Journal: JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM
Year: 2009
Reference: J Pediatr Endocrinol Metab. 2009 Aug;22(8):715-26.
Impact factor:
Publication type: Paper in international publication
Authors: Albisu, Maria A; Audi, Laura; Baguer, Luis; Bosch-Castane, Juan; Carrascosa, Antonio; Clemente, Maria; Fernandez-Cancio, Monica; Ferrandez, Angel; Gussinye, Miquel; Labarta, Jose Ignacio et al.
DOI:

Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial.

PMID: 19748319
Journal: LANCET NEUROLOGY
Year: 2009
Reference: Lancet Neurol. 2009 Nov;8(11):987-97.
Impact factor: 14.27
Publication type: Paper in international publication
Authors: Kappos, Ludwig, Freedman, Mark S, Polman, Chris H, Edan, Gilles, Hartung, Hans-Peter, Miller, David H, Montalban, Xavier, Barkhof, Frederik, Radu, Ernst-Wilhelm, Metzig, Carola et al.
DOI: 10.1016/S1474-4422(09)70237-6

Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial.

PMID: 19748319
Journal: LANCET NEUROLOGY
Year: 2009
Reference: Lancet Neurol. 2009 Nov;8(11):987-97.
Impact factor:
Publication type: Paper in international publication
Authors: Barkhof, Frederik; Bauer, Lars; Edan, Gilles; Freedman, Mark S; Hartung, Hans-Peter; Kappos, Ludwig; Lanius, Vivian; Metzig, Carola; Miller, David H; Montalban, Xavier et al.
DOI: 10.1016/S1474-4422(09)70237-6

Long-term efficacy and tolerability of 4-monthly versus yearly botulinum toxin type A treatment for lower-limb spasticity in children with cerebral palsy.

PMID: 19563586
Journal: DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY
Year: 2009
Reference: Dev Med Child Neurol. 2009 Jun;51(6):436-45.
Impact factor: 2.561
Publication type: Paper in international publication
Authors: Fontan, D, Kanovsky, Petr, Bares, Martin, Severa, Stanislav, Richardson, Alan, Kanovsky, P, Kraus, J, Severa, S, Turconi, A C, Bonikowski, M et al.
DOI: 10.1111/j.1469-8749.2008.03264.x

Long-term efficacy and tolerability of 4-monthly versus yearly botulinum toxin type A treatment for lower-limb spasticity in children with cerebral palsy.

PMID: 19563586
Journal: DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY
Year: 2009
Reference: Dev Med Child Neurol. 2009 Jun;51(6):436-45.
Impact factor:
Publication type: Paper in international publication
Authors: Bares, Martin; Benetin, J; Bonikowski, M; Cardo, E; Fontan, D; Jasinski, M; Jozwiak, M; Kanovsky, P; Kanovsky, Petr; Kraus, J et al.
DOI: 10.1111/j.1469-8749.2008.03264.x

Long-term follow-up of patients immunized with AN1792: reduced functional decline in antibody responders.

PMID: 19355849
Journal: Current Alzheimer Research
Year: 2009
Reference: Curr Alzheimer Res. 2009 Apr;6(2):144-51.
Impact factor: 4.132
Publication type: Paper in international publication
Authors: Dubois, Bruno, Flitman, Stephen, Frank-Garcia, Ana, Grosz, Daniel, Hock, Christoph, Jouanny, Pierre, Kirby, Louis, Knopman, David, Laurent, Bernard, Michel, Bernard et al.
DOI:

Long-term follow-up of patients immunized with AN1792: reduced functional decline in antibody responders.

PMID: 19355849
Journal: Current Alzheimer Research
Year: 2009
Reference: Curr Alzheimer Res. 2009 Apr;6(2):144-51.
Impact factor:
Publication type: Paper in international publication
Authors: Black, R; Boada Rovira, Merce; Brody, Mark; Corey-Bloom, Jody; Daniels, M; Dartigues, Jean-Francois; Doody, Rachelle; Dubois, Bruno; Flitman, Stephen; Fox, Nick C et al.
DOI:

Long-term results of the Spanish Protocol SO-95 for the treatment of non-metastatic high-grade osteosarcoma of the extremities in children.

PMID: 19531454
Journal: Clin Transl Oncol
Year: 2009
Reference: Clin Transl Oncol. 2009 Jun;11(6):387-92.
Impact factor:
Publication type: Letter or abstract
Authors: Munoz, Arturo, Alfaro, Jose, Pardo, Nuria, Garcia-Miguel, Purificacion, Quintero, Victor, Gros, Luis, Melero, Carmen, Antuna, Maria Jesus, Ocete, Guillermo, de Las Heras, Jorge et al.
DOI:

Long-term results of the Spanish Protocol SO-95 for the treatment of non-metastatic high-grade osteosarcoma of the extremities in children.

PMID: 19531454
Journal: Clin Transl Oncol
Year: 2009
Reference: Clin Transl Oncol. 2009 Jun;11(6):387-92.
Impact factor:
Publication type: Letter or abstract
Authors: Alfaro, Jose; Antuna, Maria Jesus; de Las Heras, Jorge; Garcia-Miguel, Purificacion; Gros, Luis; Huguet, Ramon; Maldonado, Maria Soledad; Melero, Carmen; Munoz, Arturo; Ocete, Guillermo et al.
DOI:

Loss of HER2 Amplification Following Trastuzumab-Based Neoadjuvant Systemic Therapy and Survival Outcomes.

PMID: 19920100
Journal: CLINICAL CANCER RESEARCH
Year: 2009
Reference: Clin Cancer Res. 2009 Dec 1;15(23):7381-8.
Impact factor: 6.488
Publication type: Paper in international publication
Authors: , , , , , , , , , et al.
DOI: 10.1158/1078-0432.CCR-09-1735

Loss of HER2 Amplification Following Trastuzumab-Based Neoadjuvant Systemic Therapy and Survival Outcomes.

PMID: 19920100
Journal: CLINICAL CANCER RESEARCH
Year: 2009
Reference: Clin Cancer Res. 2009 Dec 1;15(23):7381-8.
Impact factor:
Publication type: Paper in international publication
Authors: ; ; ; ; ; ; ; ; ; et al.
DOI: 10.1158/1078-0432.CCR-09-1735

Low frequency electromagnetic radiation and hearing.

PMID: 19573254
Journal: JOURNAL OF LARYNGOLOGY AND OTOLOGY
Year: 2009
Reference: J Laryngol Otol. 2009 Nov;123(11):1204-11.
Impact factor: 0.796
Publication type: Paper in international publication
Authors: Morales, J, Garcia, M, Perez, C, Valverde, J V, Lopez-Sanchez, C, Garcia-Martinez, V, Quesada, J L et al.
DOI: 10.1017/S0022215109005684

Low frequency electromagnetic radiation and hearing.

PMID: 19573254
Journal: JOURNAL OF LARYNGOLOGY AND OTOLOGY
Year: 2009
Reference: J Laryngol Otol. 2009 Nov;123(11):1204-11.
Impact factor:
Publication type: Paper in international publication
Authors: Garcia, M; Garcia-Martinez, V; Lopez-Sanchez, C; Morales, J; Perez, C; Quesada, J L; Valverde, J V et al.
DOI: 10.1017/S0022215109005684

Low-dose pioglitazone and low-dose flutamide added to metformin and oestro-progestagens for hyperinsulinaemic women with androgen excess: add-on benefits disclosed by a randomized double-placebo study over 24 months.

PMID: 19018783
Journal: CLINICAL ENDOCRINOLOGY
Year: 2009
Reference: Clin Endocrinol (Oxf). 2009 Sep;71(3):351-7.
Impact factor: 3.398
Publication type: Paper in international publication
Authors: Ibanez, Lourdes, Lopez-Bermejo, Abel, Diaz, Marta, Enriquez, Goya, del Rio, Luis, de Zegher, Francis et al.
DOI: 10.1111/j.1365-2265.2008.03472.x

Low-dose pioglitazone and low-dose flutamide added to metformin and oestro-progestagens for hyperinsulinaemic women with androgen excess: add-on benefits disclosed by a randomized double-placebo study over 24 months.

PMID: 19018783
Journal: CLINICAL ENDOCRINOLOGY
Year: 2009
Reference: Clin Endocrinol (Oxf). 2009 Sep;71(3):351-7.
Impact factor:
Publication type: Paper in international publication
Authors: de Zegher, Francis; del Rio, Luis; Diaz, Marta; Enriquez, Goya; Ibanez, Lourdes; Lopez-Bermejo, Abel et al.
DOI: 10.1111/j.1365-2265.2008.03472.x

Lower concentrations of thrombin-antithrombin complex (TAT) correlate to higher recanalisation rates among ischaemic stroke patients treated with t-PA.

PMID: 19806263
Journal: THROMBOSIS AND HAEMOSTASIS
Year: 2009
Reference: Thromb Haemost. 2009 Oct;102(4):759-64.
Impact factor: 3.803
Publication type: Paper in international publication
Authors: Fernandez-Cadenas, Israel, Mendioroz, Maite, Munuera, Josep, Alvarez-Sabin, Jose, Rovira, Alex, Quiroga, Adoracion, Corbeto, Natalia, Rubiera, Marta, Delgado, Pilar, Rosell, Anna et al.
DOI: 10.1160/TH08-06-0398

Lower concentrations of thrombin-antithrombin complex (TAT) correlate to higher recanalisation rates among ischaemic stroke patients treated with t-PA.

PMID: 19806263
Journal: THROMBOSIS AND HAEMOSTASIS
Year: 2009
Reference: Thromb Haemost. 2009 Oct;102(4):759-64.
Impact factor:
Publication type: Paper in international publication
Authors: Alvarez-Sabin, Jose; Corbeto, Natalia; Delgado, Pilar; Fernandez-Cadenas, Israel; Mendioroz, Maite; Molina, Carlos A; Montaner, Joan; Munuera, Josep; Quiroga, Adoracion; Ribo, Marc et al.
DOI: 10.1160/TH08-06-0398

Lower zinc-alpha2-glycoprotein production by adipose tissue and liver in obese patients unrelated to insulin resistance.

PMID: 19622624
Journal: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Year: 2009
Reference: J Clin Endocrinol Metab. 2009 Nov;94(11):4499-507.
Impact factor: 6.325
Publication type: Paper in international publication
Authors: Selva, David M, Lecube, Albert, Hernandez, Cristina, Baena, Juan A, Fort, Jose M, Simo, Rafael et al.
DOI: 10.1210/jc.2009-0758

Lower zinc-alpha2-glycoprotein production by adipose tissue and liver in obese patients unrelated to insulin resistance.

PMID: 19622624
Journal: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Year: 2009
Reference: J Clin Endocrinol Metab. 2009 Nov;94(11):4499-507.
Impact factor:
Publication type: Paper in international publication
Authors: Baena, Juan A; Fort, Jose M; Hernandez, Cristina; Lecube, Albert; Selva, David M; Simo, Rafael et al.
DOI: 10.1210/jc.2009-0758